AllianceBernstein’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
+11,895
| New | +$124K | ﹤0.01% | 3141 |
|
|
2024
Q2 | – | Sell |
-576
| Closed | -$11.2K | – | 3288 |
|
|
2024
Q1 | $11.2K | Hold |
576
| – | – | ﹤0.01% | 3132 |
|
|
2023
Q4 | $11.9K | Hold |
576
| – | – | ﹤0.01% | 3175 |
|
|
2023
Q3 | $18.3K | Sell |
576
-181
| -24% | -$5.76K | ﹤0.01% | 3165 |
|
|
2023
Q2 | $25.4K | Buy |
+757
| New | +$25.4K | ﹤0.01% | 3151 |
|
|
2022
Q2 | – | Sell |
-3,690
| Closed | -$136K | – | 3349 |
|
|
2022
Q1 | $136K | Buy |
3,690
+10
| +0.3% | +$369 | ﹤0.01% | 3062 |
|
|
2021
Q4 | $360K | Hold |
3,680
| – | – | ﹤0.01% | 2871 |
|
|
2021
Q3 | $459K | Hold |
3,680
| – | – | ﹤0.01% | 2779 |
|
|
2021
Q2 | $461K | Buy |
3,680
+947
| +35% | +$119K | ﹤0.01% | 2830 |
|
|
2021
Q1 | $371K | Sell |
2,733
-550
| -17% | -$74.7K | ﹤0.01% | 2803 |
|
|
2020
Q4 | $298K | Sell |
3,283
-1,680
| -34% | -$152K | ﹤0.01% | 2844 |
|
|
2020
Q3 | $369K | Sell |
4,963
-827
| -14% | -$61.5K | ﹤0.01% | 2691 |
|
|
2020
Q2 | $493K | Buy |
+5,790
| New | +$493K | ﹤0.01% | 2613 |
|